Control by Oxygen of Lens Metabolism and Cataract Formation

氧对晶状体代谢和白内障形成的控制

基本信息

  • 批准号:
    7545429
  • 负责人:
  • 金额:
    $ 54.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-01-05 至 2010-12-31
  • 项目状态:
    已结题

项目摘要

Cataract (opacification of the lens of the eye) is the primary cause of blindness in the world and costs the US Medicare program nearly $5 billion annually. Nuclear cataract (opacification of the center of the lens) is the most common form of age-related cataract. However, the causes of this disease are not well understood. Previous studies showed that exposure of the body to increased oxygen is a risk factor for nuclear cataracts in humans. The lens normally exists in a severely hypoxic environment. We found that changes in oxygen levels in the eye influence lens gene and protein expression. We also found that loss of the gel structure of the vitreous body is an important risk factor for nuclear cataracts and increases oxygen levels around the lens. Based on these and other observations described in this proposal, we propose that exposure of the lens to molecular oxygen is the primary cause of age-related nuclear cataracts and the gradual opacification of the lens nucleus that occurs with age. We will test the predictions of this hypothesis in two specific aims. In the first, we will identify the mechanisms by which oxygen regulates lens gene expression and whether oxygen levels directly contribute to the formation of nuclear cataracts. Mouse lenses that are wild type or that express stable forms of the transcription factor HIF1a will be exposed to different levels of oxygen in vivo and then microarray analysis and qPCR will be used to document changes in gene expression. This will reveal the molecular pathways by which oxygen alters lens gene expression, allowing the lens to survive in a hypoxic environment. We will also determine whether reducing the oxygen levels around the lens protects against nuclear cataract formation. This will be done by maintaining genetically modified mice that develop nuclear cataracts beginning at 6 months of age in lower levels of ambient oxygen, which lowers the oxygen levels around the lens by -50%. If molecular oxygen contributes to lens oxidative damage, this treatment will delay the formation of lens oxidative damage and opacification. By measuring oxygen levels in the eyes of patients undergoing retinal surgery we found that oxygen around the lens is elevated after vitrectomy and decreased in patients with diabetic retinopathy. Based on these data, we will test the prediction that, in patients with diabetes (lower oxygen in the vitreous body), post- vitrectomy cataracts will progress more slowly than in patients with non-ischemic retinopathy. We also observed that patients with long-standing, unilateral retinal hypoxia have less nuclear opacity in their affected (hypoxic) eye. We will compare nuclear opacity in both eyes of patients with long-standing, unilateral retinal ischemia. This study will test our prediction that oxygen from the retina is responsible for the "normal," age- related opacification of the lens nucleus.
白内障(眼睛的透镜混浊)是世界上失明的主要原因, 美国医疗保险计划每年近50亿美元。核性白内障(透镜中心混浊)是 最常见的老年性白内障然而,这种疾病的原因并不清楚。 先前的研究表明,身体暴露于增加的氧气是核辐射的危险因素。 人类的白内障透镜通常存在于严重缺氧的环境中。我们发现, 眼睛中的氧水平影响透镜基因和蛋白质的表达。我们还发现凝胶的损失 玻璃体的结构是核性白内障的重要危险因素, 在透镜周围。根据本提案中所述的这些和其他意见,我们建议, 透镜暴露于分子氧是年龄相关的核性白内障的主要原因, 随着年龄的增长,透镜核逐渐混浊。我们将检验这一假设的预测 两个具体目标。首先,我们将确定氧调节透镜基因的机制 表达和氧水平是否直接有助于核性白内障的形成。小鼠晶状体 野生型或表达稳定形式转录因子HIF 1a将暴露于不同的 体内氧水平,然后微阵列分析和qPCR将用于记录基因表达的变化。 表情这将揭示氧气改变透镜基因表达的分子途径, 使透镜在缺氧环境中存活。我们还将确定降低氧气水平 在透镜周围保护防止核性白内障形成。这将通过维持基因 在较低水平的环境中从6个月大开始发生核性白内障的改良小鼠 氧气,其使透镜周围的氧气水平降低约50%。如果分子氧有助于透镜 氧化损伤,这种治疗将延迟透镜氧化损伤和混浊的形成。 通过测量接受视网膜手术的患者眼中的氧气水平,我们发现, 透镜周围的玻璃体在玻璃体切除术后升高,而在糖尿病视网膜病变患者中降低。基于 这些数据,我们将测试预测,在糖尿病患者(玻璃体中氧含量较低), 玻璃体切除术白内障将比非缺血性视网膜病患者进展得更慢。我们也 观察到长期单侧视网膜缺氧的患者,其受影响的核混浊较少, (缺氧)眼。我们将比较长期单侧视网膜病变患者双眼的核混浊, 缺血这项研究将测试我们的预测,即来自视网膜的氧气是负责“正常”的年龄- 相关的透镜核混浊。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ischemic diabetic retinopathy may protect against nuclear sclerotic cataract.
  • DOI:
    10.1016/j.ajo.2010.05.013
  • 发表时间:
    2010-10
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Holekamp, Nancy M.;Bai, Fang;Shui, Ying-Bo;Almony, Arghavan;Beebe, David C.
  • 通讯作者:
    Beebe, David C.
Racial differences in ocular oxidative metabolism: implications for ocular disease.
Comparison of two probe designs for determining intraocular oxygen distribution.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID CY BEEBE其他文献

DAVID CY BEEBE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID CY BEEBE', 18)}}的其他基金

ORIGIN AND MAINTENANCE OF THE OCULAR SURFACE EPITHELIA
眼表上皮的起源和维持
  • 批准号:
    8514617
  • 财政年份:
    2012
  • 资助金额:
    $ 54.23万
  • 项目类别:
ORIGIN AND MAINTENANCE OF THE OCULAR SURFACE EPITHELIA
眼表上皮的起源和维持
  • 批准号:
    8343336
  • 财政年份:
    2012
  • 资助金额:
    $ 54.23万
  • 项目类别:
ORIGIN AND MAINTENANCE OF THE OCULAR SURFACE EPITHELIA
眼表上皮的起源和维持
  • 批准号:
    8675255
  • 财政年份:
    2012
  • 资助金额:
    $ 54.23万
  • 项目类别:
POST TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN THE LENS (LENS GENE EXPRESSION
晶状体基因表达的转录后控制(晶状体基因表达
  • 批准号:
    8086936
  • 财政年份:
    2011
  • 资助金额:
    $ 54.23万
  • 项目类别:
POST TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN THE LENS (LENS GENE EXPRESSION
晶状体基因表达的转录后控制(晶状体基因表达
  • 批准号:
    8634098
  • 财政年份:
    2011
  • 资助金额:
    $ 54.23万
  • 项目类别:
POST TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN THE LENS (LENS GENE EXPRESSION
晶状体基因表达的转录后控制(晶状体基因表达
  • 批准号:
    8241900
  • 财政年份:
    2011
  • 资助金额:
    $ 54.23万
  • 项目类别:
POST TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN THE LENS (LENS GENE EXPRESSION
晶状体基因表达的转录后控制(晶状体基因表达
  • 批准号:
    8445324
  • 财政年份:
    2011
  • 资助金额:
    $ 54.23万
  • 项目类别:
Control by Oxygen of Lens Metabolism and Cataract Formation
氧对晶状体代谢和白内障形成的控制
  • 批准号:
    7038514
  • 财政年份:
    2006
  • 资助金额:
    $ 54.23万
  • 项目类别:
Control by Oxygen of Lens Metabolism and Cataract Formation
氧对晶状体代谢和白内障形成的控制
  • 批准号:
    7341674
  • 财政年份:
    2006
  • 资助金额:
    $ 54.23万
  • 项目类别:
Control by Oxygen of Lens Metabolism and Cataract Formation
氧对晶状体代谢和白内障形成的控制
  • 批准号:
    7166096
  • 财政年份:
    2006
  • 资助金额:
    $ 54.23万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政​​策的情绪动态
  • 批准号:
    10108433
  • 财政年份:
    2024
  • 资助金额:
    $ 54.23万
  • 项目类别:
    EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.23万
  • 项目类别:
    Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.23万
  • 项目类别:
    Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341426
  • 财政年份:
    2024
  • 资助金额:
    $ 54.23万
  • 项目类别:
    Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341424
  • 财政年份:
    2024
  • 资助金额:
    $ 54.23万
  • 项目类别:
    Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
  • 批准号:
    2335955
  • 财政年份:
    2024
  • 资助金额:
    $ 54.23万
  • 项目类别:
    Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
  • 批准号:
    DP240103257
  • 财政年份:
    2024
  • 资助金额:
    $ 54.23万
  • 项目类别:
    Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
  • 批准号:
    DP240100408
  • 财政年份:
    2024
  • 资助金额:
    $ 54.23万
  • 项目类别:
    Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
  • 批准号:
    DP240100111
  • 财政年份:
    2024
  • 资助金额:
    $ 54.23万
  • 项目类别:
    Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
  • 批准号:
    502786
  • 财政年份:
    2024
  • 资助金额:
    $ 54.23万
  • 项目类别:
    Directed Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了